Global Gaming Console Market Industry Analysis By Type, Geography Forecast to 2021

Global gaming console market is projected to witness double digit growth over the forecast period 2016 to 2021.

PUNE, INDIA , November 14, 2016 /EINPresswire.com/ — Gaming Console Market

Global gaming console market is projected to witness double digit growth over the forecast period 2016 to 2021. The gaming console market has gone several hardware changes over the past couple of decades. Console manufacturers are coming up with new hardware so that they are compatible with latest specifications of games while enhancing the gameplay experience. Sony, Nintendo, Microsoft are the major players in the gaming console industry. Even though mobile games have found larger acceptance due to technological advancements in the smartphone industry, gaming consoles are still popular. PC games too haven’t able to dent the demand for gaming consoles, as hardcore gamers still prefer the high-end specifications of PCs, while casual gamers are more likely to opt for consoles, as they are relatively cheap and have different forms of connectivity.

Try Sample Report @ https://www.wiseguyreports.com/sample-request/646804-gaming-console-market-forecasts-from-2016-to-2021

The first section of the report deals with detailed research methodology for calculating market size and forecasts, secondary data sources used and the primary inputs which were taken for data validation. This section also outlines various segmentation which has been covered as part of the report.

Next section provides comprehensive market dynamics through an overview section along with growth drivers, challenges, and opportunities which exist in the current market. This section of the report also provides supplier and industry outlook as a whole; key industry, global and regional regulations which are determining the market growth and a brief technological aspect of gaming consoles. Complete industry analysis has also been covered by Porter’s five forces model as a part of this report section.

Access Complete Report @ https://www.wiseguyreports.com/reports/646804-gaming-console-market-forecasts-from-2016-to-2021

Thirdly, gaming console market has been segmented on the basis of type and geography. Under different types

Important regions for vendors in terms of market size is covered through detailed geographical segmentation. Geographical regions covered as a part of this section are Americas, Europe Middle East and Africa, and Asia Pacific.

Finally, competitive intelligence section deals with major players in the market, their market shares, growth strategies, products, financials, and recent investments among others. Key industry players profiled as part of this section are Sony, Nintendo, Microsoft, and Mad Catz.

Table of Contents

Introduction
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1. Market Overview and Segmentations
4.2. Drivers
4.3. Restraints
4.4. Opportunities
4.5. Industry Outlook
4.6. Porter’s 5 Forces Analysis
4.7. Industry Value Chain Analysis
5. Gaming console market Forecast by Type (US $ billion)
5.1. Home console
5.2. Handheld game consoles
6. Gaming console Market Forecast by Geography (US$ billion)
6.1. Americas
6.1.1. North America
6.1.1.1. US
6.1.1.2. Canada
6.1.2. South America
6.1.2.1. Brazil
6.1.3. Europe Middle East and Africa
6.1.3.1. Europe
6.1.3.1.1. United Kingdom
6.1.3.1.2. Germany
6.1.3.1.3. France
6.1.3.1.4. Others
6.1.3.2. The Middle East and Africa
6.1.4. Asia Pacific
6.1.4.1. Japan
6.1.4.2. China
6.1.4.3. India
6.1.4.4. Others
7. Competitive Intelligence
7.1. Market Share Analysis
7.2. Investment Analysis
7.3. Recent Deals
7.4. Strategies of Key Players
8. Company Profile
8.1. Mad Catz
8.2. Nintendo
8.3. Sony
8.4. Microsoft
Buy Report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=646804

For more information or any query mail at sales@wiseguyreports.com

Contact Us:
Norah Trent
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: PR

Anaplastic astrocytoma Therapeutic and Overview Pipeline Review H2



Wise.Guy.

Anaplastic astrocytoma Treatment Pipeline Review H2 2016

PUNE, INDIA, November 14, 2016 /EINPresswire.com/ — Anaplastic astrocytoma is a grade III tumor. It accounts for two percent of all brain tumors. It is a type of glioma that develops from star-shaped glial cells (astrocytes), which support nerve cells. Anaplastic astrocytoma grows faster and more aggressively than grade II astrocytomas. The tumor cells are not uniform in appearance and invade neighboring tissue. Symptoms include headache, weakness, clumsiness, difficulty walking and seizures. Anaplastic astrocytoma is common among men and women in their thirties to fifties and is more common in men than women. Treatment of anaplastic astrocytoma depends on the location of the tumor and how far it has progressed and usually involves surgery and radiation therapy, with chemotherapy during or following radiation.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/740556-anaplastic-astrocytoma-pipeline-review-h2-2016

Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Anaplastic Astrocytoma – Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Anaplastic Astrocytoma (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Anaplastic Astrocytoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Anaplastic Astrocytoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II and Phase I stages are 3, 7 and 7 respectively. Similarly, the Universities portfolio in Phase II and Phase I stages comprises 1 and 2 molecules, respectively.Anaplastic Astrocytoma.
Anaplastic Astrocytoma (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope
– The pipeline guide provides a snapshot of the global therapeutic landscape of Anaplastic Astrocytoma (Oncology).
– The pipeline guide reviews pipeline therapeutics for Anaplastic Astrocytoma (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Anaplastic Astrocytoma (Oncology) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Anaplastic Astrocytoma (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Anaplastic Astrocytoma (Oncology)

Reasons to buy
– Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
– Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
– Find and recognize significant and varied types of therapeutics under development for Anaplastic Astrocytoma (Oncology).
– Classify potential new clients or partners in the target demographic.
– Develop tactical initiatives by understanding the focus areas of leading companies.
– Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
– Formulate corrective measures for pipeline projects by understanding Anaplastic Astrocytoma (Oncology) pipeline depth and focus of Indication therapeutics.
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
– Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Anaplastic Astrocytoma Overview 8
Therapeutics Development 9
Pipeline Products for Anaplastic Astrocytoma – Overview 9
Pipeline Products for Anaplastic Astrocytoma – Comparative Analysis 10
Anaplastic Astrocytoma – Therapeutics under Development by Companies 11
Anaplastic Astrocytoma – Therapeutics under Investigation by Universities/Institutes 12
Anaplastic Astrocytoma – Pipeline Products Glance 13
Late Stage Products 13
Clinical Stage Products 14
Anaplastic Astrocytoma – Products under Development by Companies 15
Anaplastic Astrocytoma – Products under Investigation by Universities/Institutes 16
Anaplastic Astrocytoma – Companies Involved in Therapeutics Development 17
AngioChem Inc. 17
Astellas Pharma Inc. 18
Axelar AB 19
Boehringer Ingelheim GmbH 20
Burzynski Research Institute, Inc. 21
Cavion LLC 22
Celldex Therapeutics, Inc. 23
Millennium Pharmaceuticals Inc 24
Novartis AG 25
Orbus Therapeutics, Inc. 26
Pfizer Inc. 27
Tocagen Inc. 28
TVAX Biomedical, Inc. 29
Anaplastic Astrocytoma – Therapeutics Assessment 30
Assessment by Monotherapy Products 30
Assessment by Combination Products 31
Assessment by Target 32
Assessment by Mechanism of Action 34
Assessment by Route of Administration 36
Assessment by Molecule Type 38
Drug Profiles 40
afatinib dimaleate – Drug Profile 40
Product Description 40
Mechanism Of Action 40
R&D Progress 40
alisertib – Drug Profile 53
Product Description 53
Mechanism Of Action 53
R&D Progress 53
Antineoplaston Therapy – Drug Profile 58
Product Description 58
Mechanism Of Action 58
R&D Progress 58
AXL-1717 – Drug Profile 61
Product Description 61
Mechanism Of Action 61
R&D Progress 61
bendamustine hydrochloride – Drug Profile 63
Product Description 63
Mechanism Of Action 63
R&D Progress 63
CDX-1401 – Drug Profile 66
Product Description 66
Mechanism Of Action 66
R&D Progress 66
Cellular Immunotherapy for Gliomas – Drug Profile 69
Product Description 69
Mechanism Of Action 69
R&D Progress 69
Cellular Immunotherapy for Oncology – Drug Profile 70
Product Description 70
Mechanism Of Action 70

Access Report @ https://www.wiseguyreports.com/reports/740556-anaplastic-astrocytoma-pipeline-review-h2-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: PR

Atherosclerosis Therapeutic and Overview Pipeline Review H2



Wise.Guy.

Atherosclerosis Treatment Pipeline Review H2 2016

PUNE, INDIA, November 14, 2016 /EINPresswire.com/ — Atherosclerosis (or arteriosclerotic vascular disease) is a condition where the arteries become narrowed and hardened due to an excessive buildup of plaque around the artery wall. The disease disrupts the flow of blood around the body, posing serious cardiovascular complications. Symptoms of atherosclerosis are chest pain (angina), pain in the leg, arm, and anywhere else that an artery is blocked, shortness of breath, fatigue, confusion (if the blockage affects circulation to the brain) and muscle weakness in the legs from lack of circulation.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/740553-atherosclerosis-pipeline-review-h2-2016

Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Atherosclerosis – Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Atherosclerosis (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Atherosclerosis (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Atherosclerosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 5, 5, 43 and 14 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 25 and 4 molecules, respectively.Atherosclerosis.

Atherosclerosis (Cardiovascular) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantageAdditionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope
– The pipeline guide provides a snapshot of the global therapeutic landscape of Atherosclerosis (Cardiovascular).
– The pipeline guide reviews pipeline therapeutics for Atherosclerosis (Cardiovascular) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Atherosclerosis (Cardiovascular) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Atherosclerosis (Cardiovascular) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Atherosclerosis (Cardiovascular)

Reasons to buy
– Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
– Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
– Find and recognize significant and varied types of therapeutics under development for Atherosclerosis (Cardiovascular).
– Classify potential new clients or partners in the target demographic.
– Develop tactical initiatives by understanding the focus areas of leading companies.
– Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
– Formulate corrective measures for pipeline projects by understanding Atherosclerosis (Cardiovascular) pipeline depth and focus of Indication therapeutics.
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
– Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents
Table of Contents 2
Introduction 6
Atherosclerosis Overview 7
Therapeutics Development 8
Atherosclerosis – Therapeutics under Development by Companies 10
Atherosclerosis – Therapeutics under Investigation by Universities/Institutes 13
Atherosclerosis – Pipeline Products Glance 15
Atherosclerosis – Products under Development by Companies 18
Atherosclerosis – Products under Investigation by Universities/Institutes 22
Atherosclerosis – Companies Involved in Therapeutics Development 24
Atherosclerosis – Therapeutics Assessment 63
Drug Profiles 77
Atherosclerosis – Dormant Projects 210
Atherosclerosis – Discontinued Products 222
Atherosclerosis – Product Development Milestones 225

Access Report @ https://www.wiseguyreports.com/reports/740553-atherosclerosis-pipeline-review-h2-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: PR

Welding Materials Global Market Growth, Intended Audience, Key Players Analysis and Forecast to 2022



Market Size of Welding Materials by Regions

Market Research Future published a Half-Cooked Research Report on Global Welding Materials Market that contains the information from 2014 to 2022.

PUNE, MAHARASHTRA, INDIA, November 14, 2016 /EINPresswire.com/ — Global Welding Materials market is expected to grow with the CAGR of approximately 5% from 2016 to 2022, and with this it is predictable to cross USD 16 Billion by 2022.

Target Audience
o Manufactures
o Raw Materials Suppliers
o Aftermarket suppliers
o Research Institute / Education Institute
o Potential Investors
o Key executive (CEO and COO) and strategy growth manager

Market Highlights
Welding is a process of joining metals by causing fusion. It is a very cost effective process, which finds its application in industries such as transportation, construction, oil & gas and power. The growth of the welding industry is highly dependent on the consumption of steel in various end-use industries. The welding technology comprises of welding materials and welding services. The welding materials accounts for a significant share in the welding industry.

“Ask for your specific company profile and country level customization on reports.”

Key Players
• Air Products and Chemicals Inc.
• Illinois Tools Works Inc.
• Sandvik AB
• Praxair Incorporated
• Air Liquide S.A.
• Colfax Corporation
• The Linde Group
• Lincoln Electric Holdings, Inc.
• Tianjin Bridge Welding Materials Group Co., Ltd.

Get a Sample Report @ https://www.marketresearchfuture.com/sample-request/global-welding-materials-market-research-report-forecast-to-2022

The global welding materials market is driven by the growth in transportation, manufacturing, and building & construction industries. The transportation industry is the largest consumer of such material due to its usage in automobile industry. The automobile industry has a matured market in North America and Europe which is expected to grow steadily over the forecasted period. The market is driven by the demand from APAC region. The transportation & automobile industries have lot of scope for growth in the region due to rapid urbanization and increasing disposable income. This augments the demand for welding materials across all the processes of automobile and parts manufacturing.

Market Segments
On The Basis Of Type
o Electrode
o Flux & Wires
o Gases

On The Basis Of Application
o Construction
o Transportation
o Oil & Gas
o Power

Taste the market data and market information presented through more than 85 market data tables and figures spread in 116 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Global Welding Materials Market Information to 2022"

Furthermore, the cost effectiveness of the welding materials is driving the growth of the market. Many players are now expanding their portfolio by adding different welding material types such as flux & wires and gases in order to serve the various industries better. Flux & wires show properties such as high deposition rate and strong welds which is highly suitable for outdoor work.

The region of APAC has witnessed a remarkable growth in the Welding Materials Market due to high demands from the lands of China and India. The increased investments in India in both automobile and construction industry have widened the scope for welding materials. Also, APAC is currently valued as the largest and fastest growing market for this material and is expected to keep up the pace by 2022. The global welding materials market is expected to cross USD 16 Billion mark at the end of the forecasted period and is expected to show a staggering growth at CAGR of approximately 5% from 2016 to 2022.

Browse Report @ https://www.marketresearchfuture.com/reports/global-welding-materials-market-research-report-forecast-to-2022

Table of Content
1 Executive Summary
2 Scope of the Report
2.1 Market Definition
2.2 Scope of the Study
2.2.1 Research Objectives
2.2.2 Assumptions & Limitations
2.3 Markets Structure
3 Market Research Methodologies
3.1 Research Process
3.2 Secondary Research
3.3 Primary Research
3.4 Forecast Model
4 Market Landscape
4.1 Five Forces Analysis
4.1.1 Threat of New Entrants
4.1.2 Bargaining power of buyers
4.1.3 Threat of substitutes
4.1.4 Segment rivalry
4.2 Value Chain of Global Welding Materials Market
5 Industry Overview of Global Welding Materials Market
5.1 Introduction
5.2 Growth Drivers
5.3 Impact analysis
5.4 Market Challenges
5.5 Impact analysis
6 Market Trends
6.1 Introduction
6.2 Growth Trends
6.3 Impact analysis
7. Global Welding Materials Market by Region
8. Global Welding Materials Market by Type
9. Global Welding Materials Market by Application
Continue……….

Scope of the report
This study provides an overview of the global Welding Materials Industry, tracking two market segments across four geographic regions. The report studies key players, providing a five-year annual trend analysis that highlights market size, volume and share for North America, Europe, Asia Pacific, and Rest of the World. The report also provides a forecast, focusing on the market opportunities for the next five years for each region. The scope of the study segments the global welding materials market as type and application.

Related Report
Global Polysilicon Market Information by Purity Grade (Electronic Grade, Medium Grade, and Upgraded Metallurgical Grade) by Form (Chunk, Granule, and others) by End-use (PV Industry and Semiconductor Industry) and by Region – Forecast to 2022 More Details @ https://www.marketresearchfuture.com/reports/global-polysilicon-market-research-report-forecast-to-2022

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Akash Anand
Market Research Future
+1 646 845 9312
email us here

Source: PR

Global Aerostat Systems Market 2016 Share, Trend, Segmentation and Forecast to 2021

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer

PUNE, INDIA, November 14, 2016 /EINPresswire.com/ — Aerostat Systems

Notes:

Production, means the output of Aerostat Systems

Revenue, means the sales value of Aerostat Systems

This report studies Aerostat Systems in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/739410-global-aerostat-systems-market-research-report-2016

Lockheed Martin
Raytheon
Tcom L.P.
Raven Industries
Augur Rosaerosystems
Exelis (Harris Corporation)
RT LTA Systems
Near Space Systems
Aeroscraft Corporation
Lindstrand Technologies
Rafael Advanced Defense Systems

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Aerostat Systems in these regions, from 2011 to 2021 (forecast), like

North America
Europe
China
Japan
Southeast Asia
India

Would like to place an order @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=739410

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

Rigid
Non-rigid
Semi-rigid

Split by application, this report focuses on consumption, market share and growth rate of Aerostat Systems in each application, can be divided into

Civil use
Military use
Application 3

Table of Contents

Global Aerostat Systems Market Research Report 2016

1 Aerostat Systems Market Overview

1.1 Product Overview and Scope of Aerostat Systems

1.2 Aerostat Systems Segment by Type

1.2.1 Global Production Market Share of Aerostat Systems by Type in 2015

1.2.2 Rigid

1.2.3 Non-rigid

1.2.4 Semi-rigid

1.3 Aerostat Systems Segment by Application

1.3.1 Aerostat Systems Consumption Market Share by Application in 2015

1.3.2 Civil use

1.3.3 Military use

1.3.4 Application 3

1.4 Aerostat Systems Market by Region

1.4.1 North America Status and Prospect (2011-2021)

1.4.2 Europe Status and Prospect (2011-2021)

1.4.3 China Status and Prospect (2011-2021)

1.4.4 Japan Status and Prospect (2011-2021)

1.4.5 Southeast Asia Status and Prospect (2011-2021)

1.4.6 India Status and Prospect (2011-2021)

1.5 Global Market Size (Value) of Aerostat Systems (2011-2021)

2 Global Aerostat Systems Market Competition by Manufacturers

2.1 Global Aerostat Systems Production and Share by Manufacturers (2015 and 2016)

2.2 Global Aerostat Systems Revenue and Share by Manufacturers (2015 and 2016)

2.3 Global Aerostat Systems Average Price by Manufacturers (2015 and 2016)

2.4 Manufacturers Aerostat Systems Manufacturing Base Distribution, Sales Area and Product Type

2.5 Aerostat Systems Market Competitive Situation and Trends

2.5.1 Aerostat Systems Market Concentration Rate

2.5.2 Aerostat Systems Market Share of Top 3 and Top 5 Manufacturers

2.5.3 Mergers & Acquisitions, Expansion

3 Global Aerostat Systems Production, Revenue (Value) by Region (2011-2016)

3.1 Global Aerostat Systems Production by Region (2011-2016)

3.2 Global Aerostat Systems Production Market Share by Region (2011-2016)

3.3 Global Aerostat Systems Revenue (Value) and Market Share by Region (2011-2016)

3.4 Global Aerostat Systems Production, Revenue, Price and Gross Margin (2011-2016)

3.5 North America Aerostat Systems Production, Revenue, Price and Gross Margin (2011-2016)

3.6 Europe Aerostat Systems Production, Revenue, Price and Gross Margin (2011-2016)

3.7 China Aerostat Systems Production, Revenue, Price and Gross Margin (2011-2016)

3.8 Japan Aerostat Systems Production, Revenue, Price and Gross Margin (2011-2016)

3.9 Southeast Asia Aerostat Systems Production, Revenue, Price and Gross Margin (2011-2016)

3.10 India Aerostat Systems Production, Revenue, Price and Gross Margin (2011-2016)

4 Global Aerostat Systems Supply (Production), Consumption, Export, Import by Regions (2011-2016)

4.1 Global Aerostat Systems Consumption by Regions (2011-2016)

4.2 North America Aerostat Systems Production, Consumption, Export, Import by Regions (2011-2016)

4.3 Europe Aerostat Systems Production, Consumption, Export, Import by Regions (2011-2016)

4.4 China Aerostat Systems Production, Consumption, Export, Import by Regions (2011-2016)

4.5 Japan Aerostat Systems Production, Consumption, Export, Import by Regions (2011-2016)

4.6 Southeast Asia Aerostat Systems Production, Consumption, Export, Import by Regions (2011-2016)

4.7 India Aerostat Systems Production, Consumption, Export, Import by Regions (2011-2016)

5 Global Aerostat Systems Production, Revenue (Value), Price Trend by Type

5.1 Global Aerostat Systems Production and Market Share by Type (2011-2016)

5.2 Global Aerostat Systems Revenue and Market Share by Type (2011-2016)

5.3 Global Aerostat Systems Price by Type (2011-2016)

5.4 Global Aerostat Systems Production Growth by Type (2011-2016)

……Continued

Access Complete Report@ https://www.wiseguyreports.com/reports/739410-global-aerostat-systems-market-research-report-2016

NORAH TRENT
Wise Guy Reports
+91 841 198 5042
email us here

Source: PR

Tile Adhesives Market: Consumption, Demand, Sales, Competitor and Forecast 2016 – 2022

Drivers of Tile Adhesives Market

Market Research Future published a Half-Cooked Research Report on Global Tile Adhesives Market that contains the information from 2014 to 2022.

PUNE, MAHARASHTRA, INDIA, November 14, 2016 /EINPresswire.com/ — Global Tile Adhesives Market is expected to grow with the CAGR of more than 10% from 2016 to 2022, and with this it is predictable to cross USD 4.5 Billion by 2022.

Market Highlights
Over the past few years, the global market has seen a significant growth due to increasing tile adhesive demand. This results into a higher growth rate at the end of forecasted period. As per the MRFR analysis, different factors have created boom in the Global Tile Adhesive Market are rising application segment, increasing construction projects and rising trend for ceramic as well as decorative tiles.

List of Figures
Figure 1 Global Tile Adhesives Market Segmentation
Figure 2 Forecast Methodology
Figure 3 Five Forces Analysis of Global Tile Adhesives Market
Figure 4 Value Chain of Global Tile Adhesives Market
Figure 5 Share of Global Tile Adhesives Market In 2014, By Country (In %)
Figure 6 Global Tile Adhesives Market, 2015-2022, (USD Billion)
Figure 7 Sub-Segments of Applications
Figure 8 Global Tile Adhesives Market Size by Application, 2015
Figure 9 Share of Global Tile Adhesives Market by Application, 2012 To 2022
Figure 10 Global Tile Adhesives Market Size by Product Type, 2015
Figure 11 Share of Global Tile Adhesives Market by Product Type, 2012 To 2022

“Ask for your specific company profile and country level customization on reports”

Key Players
• Ardex Group
• Bostik
• Terraco
• Sika AG
• H.B. Fuller
• Pidilite Industries
• Mapei S.P.A.
• Laticrete International
• Saint-Gobain Weber
• Fosroc

Get a Sample Report @ https://www.marketresearchfuture.com/sample-request/tile-adhesive-market-research-report-global-forecast-to-2022

Scope of the study
The scope of the study categorizes the tile adhesive market as product type and application.
By Product type
o Latex Mortar
o Acrylic-Mixed Mortar
o Epoxy Mortar

By Application
o Residential
o Non – Residential

List of Tables
Table 1 World Population By Major Regions (2015 To 2030) (Million)
Table 2 Global Tile Adhesives Market: By Region, 2014-2022 (USD Million)
Table 3 North America Global Tile Adhesives Market: By Country, 2014-2022 (USD Million)
Table 4 Europe Global Tile Adhesives Market: By Country, 2014-2022 (USD Million)
Table 5 Asia-Pacific Global Tile Adhesives Market: By Country, 2014-2022 (USD Million)
Table 6 RoW Global Tile Adhesives Market: By Country, 2014-2022 (USD Million)
Table 7 Global Tile Adhesives for Product Type Market: By Regions, 2014-2022 (USD Million)
Table 8 North America Global Tile Adhesives for Product Type Market: By Country, 2014-2022 (USD Million)
Table 9 Europe Global Tile Adhesives for Product Type Market: By Country, 2014-2022 (USD Million)
Table 10 Asia-Pacific Global Tile Adhesives for Product Type Market: By Country, 2014-2022 (USD Million)
Table 11 RoW Global Tile Adhesives for Product Type Market: By Country, 2014-2022 (USD Million)
Table 12 North America Global Tile Adhesives for Application Market: By Country, 2014-2022 (USD Million)
Table 13 Europe Global Tile Adhesives for Application Market: By Country, 2014-2022 (USD Million)
Table 14 Asia-Pacific Global Tile Adhesives for Application Market: By Country, 2014-2022 (USD Million)
Table 15 RoW Global Tile Adhesives for Application Market: By Country, 2014-2022 (USD Million)
Table 16 Global Tile Adhesives for Application Market: By Region, 2014-2022 (USD Million)
Table 17 North America Global Tile Adhesives for Application Market: By Country, 2014-2022 (USD Million)
Table 18 Europe Global Tile Adhesives for Application Market: By Country, 2014-2022 (USD Million)
Table 19 Asia-Pacific Global Tile Adhesives for Application Market: By Country, 2014-2022 (USD Million)
Table 20 RoW Global Tile Adhesives for Application Market: By Country, 2014-2022 (USD Million)
Continue…….

Taste the market data and market information presented through more than 100 market data tables and figures spread in 138 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Global Tile Adhesives Market Information from 2014 to 2022"

Regional Analysis
“Asia-Pacific is projected to be the largest market during the forecast period”
Geographically, Asia-Pacific is expected to be the largest market for tile adhesive China is one of the largest manufacturer of tile adhesives which has also created a platform for the APAC countries. Along with this, the rising construction and residential properties in China, India, Indonesia, and Singapore have been a major growing factors which has fueled the demand for tile adhesives in the regional as well as global market. Followed by this North America is expected to be the second ruling region and Europe would be on third position.

Target Audience
o Manufactures of end-use industry
o Raw material Suppliers
o Aftermarket suppliers
o Research Institute / Education Institute
o Potential Investors
o Key executive (CEO and COO) and strategy growth manager

Browse Report @ https://www.marketresearchfuture.com/reports/tile-adhesive-market-research-report-global-forecast-to-2022

Table of Content
1 Executive Summary
2 Scope of the Report
2.1 Market Definition
2.2 Scope of the Study
2.2.1 Research Objectives
2.2.2 Assumptions & Limitations
2.3 Markets Structure
3 Market Research Methodologies
3.1 Research Process
3.2 Secondary Research
3.3 Primary Research
3.4 Forecast Model
4 Market Landscape
4.1 Five Forces Analysis
4.1.1 Threat of New Entrants
4.1.2 Bargaining power of buyers
4.1.3 Threat of substitutes
4.1.4 Segment rivalry
4.2 Value Chain/Supply Chain of Global Tile Adhesives Market
5 Industry Overview of Global Tile Adhesives Market
5.1 Introduction
5.2 Growth Drivers
5.3 Impact analysis
5.4 Market Challenges
5.5 Impact analysis
6 Market Trends
6.1 Introduction
6.2 Growth Trends
6.3 Impact analysis
7. Global Tile Adhesives Market by Region
Continue………..

Related Report
Global Welding Materials Market Information by Type (Electrodes, Flux & Wires, Gases, and others) by Application (Construction, Transportation, Oil & Gas, Power, and others) and by Region – Forecast to 2022. Browse full report @ https://www.marketresearchfuture.com/reports/global-welding-materials-market-research-report-forecast-to-2022

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Akash Anand
Market Research Future
+1 646 845 9312
email us here

Source: PR

Security Robots Market By Applications,Types,Regions And Companies Market Research Report To 2021



Wise.Guy.

PUNE, INDIA, November 14, 2016 /EINPresswire.com/ —

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/739183-global-security-robots-market-research-report-to-2020

This report studies Security Robots in Global market, especially in North America, Europe, China, Japan, India and Southeast Asia, focuses on top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering
Lockheed Martin Corp.
Northrop Grumman Corp.
BAE Systems PLC
Thales SA
Elbit Systems
Irobot Corp.
Qinetiq Group PLC
Finmeccanica SPA
Aerovironment, Inc.
Knightscope, Inc.
Recon Robotics
DJI
Boston Dynamics
Kongsberg Gruppen
Cobham PLC

Market Segment by Regions, this report splits Global into several key Regions, with sales, revenue, market share and growth rate of Security Robots in these regions, from 2011 to 2020 (forecast), like
North America
China
Europe
Japan
Taiwan
Korea

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Unmanned aerial vehicles
Unmanned ground vehicles
Unmanned underwater vehicles

Split by applications, this report focuses on sales, market share and growth rate of Security Robots in each application, can be divided into
Spying
Explosive detection
Firefighting
Demining
Rescue operations
Transportation
Patrolling

Complete Report Details @ https://www.wiseguyreports.com/reports/739183-global-security-robots-market-research-report-to-2020

Table of Contents

Global Security Robots Market Research Report 2021

1 Security Robots Overview
1.1 Product Overview and Scope of Security Robots
1.2 Security Robots Segment by Types
1.2.1 Global Sales Market Share of Security Robots by Types in 2015
1.2.2 Unmanned aerial vehicles
1.2.3 Unmanned ground vehicles
1.2.4 Unmanned underwater vehicles
1.3 Security Robots Segment by Applications/End Users
1.3.1 Spying
1.3.2 Explosive detection
1.3.3 Firefighting
1.3.4 Demining
1.3.5 Rescue operations
1.3.6 Transportation
1.3.7 Patrolling
1.4 Security Robots Market by Regions
1.4.1 North America Status and Prospect (2011-2020)
1.4.2 China Status and Prospect (2011-2020)
1.4.3 Europe Status and Prospect (2011-2020)
1.4.4 Japan Status and Prospect (2011-2020)
1.4.5 Taiwan Status and Prospect (2011-2020)
1.4.6 Korea Status and Prospect (2011-2020)
1.5 Global Market Size (Value and Volume) of Security Robots (2011-2020)
1.5.1 Global Security Robots Sales and Revenue (2011-2020)
1.5.2 Global Security Robots Sales and Growth Rate (2011-2020)
1.5.3 Global Security Robots Revenue and Growth Rate (2011-2020)

2 Global Security Robots Market Competition by Manufacturers
2.1 Global Security Robots Sales and Share by Manufacturers (2015 and 2016)
2.2 Global Security Robots Revenue and Share by Manufacturers (2015 and 2016)
2.3 Manufacturers Security Robots Manufacturing Base Distribution and Product Types
2.4 Competitive Situation and Trends
2.4.1 Expansions
2.4.2 New Product Launches
2.4.3 Acquisitions
2.4.4 Other Developments

3 Global Security Robots Analysis by Regions
3.1 Global Security Robots Sales, Revenue and Market Share by Regions (2011-2020)
3.1.1 Global Security Robots Sales Market Share by Regions (2011-2020)
3.1.2 Global Security Robots Revenue Market Share by Regions (2011-2020)
3.2 North America
3.2.1 North America Security Robots Sales, Revenue and Price (2011-2020)
3.2.2 North America Security Robots Sales, Revenue and Growth Rate (2011-2020)
3.3 Europe
3.3.1 Europe Security Robots Sales, Revenue and Price (2011-2020)
3.3.2 Europe Security Robots Sales, Revenue and Growth Rate (2011-2020)
3.4 China
3.4.1 China Security Robots Sales, Revenue and Price (2011-2020)
3.4.2 China Security Robots Sales, Revenue and Growth Rate (2011-2020)
3.5 Japan
3.5.1 Japan Security Robots Sales, Revenue and Price (2011-2020)
3.5.2 Japan Security Robots Sales, Revenue and Growth Rate (2011-2020)
3.6 Taiwan
3.6.1 Taiwan Security Robots Sales, Revenue and Price (2011-2020)
3.6.2 Taiwan Security Robots Sales, Revenue and Growth Rate (2011-2020)
3.7 Korea
3.7.1 Korea Security Robots Sales, Revenue and Price (2011-2020)
3.7.2 Korea Security Robots Sales, Revenue and Growth Rate (2011-2020)

4 Global Security Robots Analysis by Types
4.1 Global Security Robots Sales, Revenue, Market Share and Growth Rate by Types (2011-2020)
4.1.1 Global Security Robots Sales and Market Share by Types (2011-2020)
4.1.2 Global Security Robots Revenue, Market Share and Growth Rate by Types (2011-2020)
4.2 Unmanned aerial vehicles Sales, Revenue, Price and Growth (2011-2020)
4.3 Unmanned ground vehicles Sales, Revenue, Price and Growth (2011-2020)
4.4 Unmanned underwater vehicles Sales, Revenue, Price and Growth (2011-2020)

……….

6 Global Security Robots Manufacturers Analysis
6.1 Lockheed Martin Corp.
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Security Robots Product Overview and End Users
6.1.2.1 Unmanned aerial vehicles
6.1.2.2 Unmanned ground vehicles
6.1.2.3 Unmanned underwater vehicles
6.1.3 Security Robots Sales, Revenue, Price of Lockheed Martin Corp. (2015 and 2016)
6.2 Northrop Grumman Corp.
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Security Robots Product Overview and End Users
6.2.2.1 Unmanned aerial vehicles
6.2.2.2 Unmanned ground vehicles
6.2.2.3 Unmanned underwater vehicles
6.2.3 Security Robots Sales, Revenue, Price of Northrop Grumman Corp. (2015 and 2016)
6.3 BAE Systems PLC
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Security Robots Product Overview and End Users
6.3.2.1 Unmanned aerial vehicles
6.3.2.2 Unmanned ground vehicles
6.3.2.3 Unmanned underwater vehicles
6.3.3 Security Robots Sales, Revenue, Price of BAE Systems PLC (2015 and 2016)
6.4 Thales SA
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Security Robots Product Overview and End Users
6.4.2.1 Unmanned aerial vehicles
6.4.2.2 Unmanned ground vehicles
6.4.3 Security Robots Sales, Revenue, Price of Thales SA (2015 and 2016)
6.5 Elbit Systems
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Security Robots Product Overview and End Users
6.5.2.1 Unmanned aerial vehicles
6.5.2.2 Unmanned ground vehicles
6.5.3 Security Robots Sales, Revenue, Price of Elbit Systems (2015 and 2016)

…..Continued

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=739183

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: PR

Oropharyngeal cancer Therapeutic and Overview Pipeline Review H2



Wise.Guy.

Oropharyngeal cancer Treatment Pipeline Review H2 2016

PUNE, INDIA, November 14, 2016 /EINPresswire.com/ — Oropharyngeal cancer is a disease which malignant cells form in the tissue of oropharynx. Oropharynx is a middle part of the throat which includes the base of the tongue, the tonsils, the soft palate, and the walls of the pharynx. Oropharyngeal cancers can be divided into two types, HPV-positive, which are related to human papillomavirus infection, and HPV-negative cancers, which are usually linked to alcohol or tobacco use.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/740552-oropharyngeal-cancer-pipeline-review-h2-2016

Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Oropharyngeal Cancer – Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Oropharyngeal Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Oropharyngeal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Oropharyngeal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 3, 5, 5 and 1 respectively. Similarly, the Universities portfolio in Phase I and Preclinical stages comprises 1 and 1 molecules, respectively.Oropharyngeal Cancer.

Oropharyngeal Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope
– The pipeline guide provides a snapshot of the global therapeutic landscape of Oropharyngeal Cancer (Oncology).
– The pipeline guide reviews pipeline therapeutics for Oropharyngeal Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Oropharyngeal Cancer (Oncology) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Oropharyngeal Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Oropharyngeal Cancer (Oncology)

Reasons to buy
– Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
– Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
– Find and recognize significant and varied types of therapeutics under development for Oropharyngeal Cancer (Oncology).
– Classify potential new clients or partners in the target demographic.
– Develop tactical initiatives by understanding the focus areas of leading companies.
– Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
– Formulate corrective measures for pipeline projects by understanding Oropharyngeal Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
– Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Oropharyngeal Cancer Overview 8
Therapeutics Development 9
Pipeline Products for Oropharyngeal Cancer – Overview 9
Pipeline Products for Oropharyngeal Cancer – Comparative Analysis 10
Oropharyngeal Cancer – Therapeutics under Development by Companies 11
Oropharyngeal Cancer – Therapeutics under Investigation by Universities/Institutes 12
Oropharyngeal Cancer – Pipeline Products Glance 13
Late Stage Products 13
Clinical Stage Products 14
Early Stage Products 15
Oropharyngeal Cancer – Products under Development by Companies 16
Oropharyngeal Cancer – Products under Investigation by Universities/Institutes 17
Oropharyngeal Cancer – Companies Involved in Therapeutics Development 18
Advaxis, Inc. 18
AstraZeneca Plc 19
Cell Medica Limited 20
Genticel S.A. 21
Immunovaccine Inc 22
ISA Pharmaceuticals B.V. 23
Kolltan Pharmaceuticals, Inc. 24
Merck & Co., Inc. 25
Novartis AG 26
PNP Therapeutics, Inc. 27
Tessa Therapeutics Pte Ltd 28
VLPbio 29
Oropharyngeal Cancer – Therapeutics Assessment 30
Assessment by Monotherapy Products 30
Assessment by Target 31
Assessment by Mechanism of Action 33
Assessment by Route of Administration 35
Assessment by Molecule Type 37
Drug Profiles 39
alpelisib – Drug Profile 39
Product Description 39
Mechanism Of Action 39
R&D Progress 39
axalimogene filolisbac – Drug Profile 42
Product Description 42
Mechanism Of Action 42
R&D Progress 42
Cellular Immunotherapy for HPV Associated Cancers – Drug Profile 58
Product Description 58
Mechanism Of Action 58
R&D Progress 58
CMD-004 – Drug Profile 59
Product Description 59
Mechanism Of Action 59
R&D Progress 59
DPXE-7 – Drug Profile 60
Product Description 60
Mechanism Of Action 60
R&D Progress 60
ganetespib – Drug Profile 61
Product Description 61
Mechanism Of Action 61
R&D Progress 61
gedeptin – Drug Profile 74
Product Description 74

Access Report @ https://www.wiseguyreports.com/reports/740552-oropharyngeal-cancer-pipeline-review-h2-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: PR

Cataract Therapeutic and Overview Pipeline Review H2



Wise.Guy.

Cataract Treatment Pipeline Review H2 2016

PUNE, INDIA, November 14, 2016 /EINPresswire.com/ — Cataract is a clouding of the normally clear lens of eye that affects vision. Symptoms include clouded, blurred or dim vision, increasing difficulty with vision at night, fading or yellowing of colors, double vision in a single eye and frequent prescription changes in eye wear. Risk factors include age, diabetes, drinking excessive amounts of alcohol, high blood pressure, obesity and smoking.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/740549-cataract-pipeline-review-h2-2016

Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Cataract – Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Cataract (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Cataract (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Cataract and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Preclinical and Discovery stages are 1, 4 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 2 molecules, respectively.Cataract.

Cataract (Ophthalmology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope
– The pipeline guide provides a snapshot of the global therapeutic landscape of Cataract (Ophthalmology).
– The pipeline guide reviews pipeline therapeutics for Cataract (Ophthalmology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Cataract (Ophthalmology) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Cataract (Ophthalmology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Cataract (Ophthalmology)

Reasons to buy
– Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
– Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
– Find and recognize significant and varied types of therapeutics under development for Cataract (Ophthalmology).
– Classify potential new clients or partners in the target demographic.
– Develop tactical initiatives by understanding the focus areas of leading companies.
– Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
– Formulate corrective measures for pipeline projects by understanding Cataract (Ophthalmology) pipeline depth and focus of Indication therapeutics.
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
– Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Cataract Overview 6
Therapeutics Development 7
Pipeline Products for Cataract – Overview 7
Pipeline Products for Cataract – Comparative Analysis 8
Cataract – Therapeutics under Development by Companies 9
Cataract – Therapeutics under Investigation by Universities/Institutes 10
Cataract – Pipeline Products Glance 11
Clinical Stage Products 11
Early Stage Products 12
Cataract – Products under Development by Companies 13
Cataract – Products under Investigation by Universities/Institutes 14
Cataract – Companies Involved in Therapeutics Development 15
EyeGate Pharmaceuticals, Inc. 15
Genisphere LLC 16
Omeros Corporation 17
Plex Pharmaceuticals, Inc. 18
Cataract – Therapeutics Assessment 19
Assessment by Monotherapy Products 19
Assessment by Target 20
Assessment by Mechanism of Action 22
Assessment by Route of Administration 24
Assessment by Molecule Type 26
Drug Profiles 28
dexamethasone acetate – Drug Profile 28
Product Description 28
Mechanism Of Action 28
R&D Progress 28
GL-249 – Drug Profile 32
Product Description 32
Mechanism Of Action 32
R&D Progress 32
lanosterol – Drug Profile 33
Product Description 33
Mechanism Of Action 33
R&D Progress 33
Small Molecule for Non-Surgical Cataracts and Multiple Sclerosis – Drug Profile 34
Product Description 34
Mechanism Of Action 34
R&D Progress 34
Small Molecule to Antagonize GPR161 for Central Nervous System Disorders, Oncology and Ophthalmology – Drug Profile 35

Access Report @ https://www.wiseguyreports.com/reports/740549-cataract-pipeline-review-h2-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: PR

Global Cell Isolation Beads Market 2016 Share, Trend, Segmentation and Forecast to 2021

This report studies Cell Isolation Beads in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India

PUNE, MAHARASTRA, INDIA, November 14, 2016 /EINPresswire.com/ —

Summary

This report studies Cell Isolation Beads in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Beckman Coulter (Subsidiary of Danaher Corporation)
Becton, Dickinson and Company
GE Healthcare (A Fully Owned Subsidiary of General Electric Company)
Merck KGaA
Thermo Fisher Scientific Inc.
Miltenyi Biotec
Pluriselect Life Science
Stemcell Technologies Inc.
Terumo Bct (A Subsidiary of Terumo Corporation)
Bio-Rad Laboratories, Inc.

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/739420-global-cell-isolation-beads-market-research-report-2016

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Cell Isolation Beads in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Human Cells
Differentiated Cells
Stem Cells
Animal Cells

Split by application, this report focuses on consumption, market share and growth rate of Cell Isolation Beads in each application, can be divided into
Research Laboratories and Institutes
Hospitals and Diagnostic Laboratories
Cell Banks
Biotechnology and Biopharmaceutical Companies

At any Query @ https://www.wiseguyreports.com/enquiry/739420-global-cell-isolation-beads-market-research-report-2016

Table of Contents

Global Cell Isolation Beads Market Research Report 2016
1 Cell Isolation Beads Market Overview
1.1 Product Overview and Scope of Cell Isolation Beads
1.2 Cell Isolation Beads Segment by Type
1.2.1 Global Production Market Share of Cell Isolation Beads by Type in 2015
1.2.2 Human Cells
1.2.3 Differentiated Cells
1.2.4 Stem Cells
1.2.5 Animal Cells
1.3 Cell Isolation Beads Segment by Application
1.3.1 Cell Isolation Beads Consumption Market Share by Application in 2015
1.3.2 Research Laboratories and Institutes
1.3.3 Hospitals and Diagnostic Laboratories
1.3.4 Cell Banks
1.3.5 Biotechnology and Biopharmaceutical Companies
1.4 Cell Isolation Beads Market by Region
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 China Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Cell Isolation Beads (2011-2021)

7 Global Cell Isolation Beads Manufacturers Profiles/Analysis
7.1 Beckman Coulter (Subsidiary of Danaher Corporation)
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Cell Isolation Beads Product Type, Application and Specification
7.1.2.1 Type I
7.1.2.2 Type II
7.1.3 Beckman Coulter (Subsidiary of Danaher Corporation) Cell Isolation Beads Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 Becton, Dickinson and Company
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Cell Isolation Beads Product Type, Application and Specification
7.2.2.1 Type I
7.2.2.2 Type II
7.2.3 Becton, Dickinson and Company Cell Isolation Beads Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 GE Healthcare (A Fully Owned Subsidiary of General Electric Company)
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Cell Isolation Beads Product Type, Application and Specification
7.3.2.1 Type I
7.3.2.2 Type II
7.3.3 GE Healthcare (A Fully Owned Subsidiary of General Electric Company) Cell Isolation Beads Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 Merck KGaA
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 Cell Isolation Beads Product Type, Application and Specification
7.4.2.1 Type I
7.4.2.2 Type II
7.4.3 Merck KGaA Cell Isolation Beads Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
7.5 Thermo Fisher Scientific Inc.
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
7.5.2 Cell Isolation Beads Product Type, Application and Specification
7.5.2.1 Type I
7.5.2.2 Type II
7.5.3 Thermo Fisher Scientific Inc. Cell Isolation Beads Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5.4 Main Business/Business Overview
7.6 Miltenyi Biotec
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
7.6.2 Cell Isolation Beads Product Type, Application and Specification
7.6.2.1 Type I
7.6.2.2 Type II
7.6.3 Miltenyi Biotec Cell Isolation Beads Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview
7.7 Pluriselect Life Science
7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
7.7.2 Cell Isolation Beads Product Type, Application and Specification
7.7.2.1 Type I
7.7.2.2 Type II
7.7.3 Pluriselect Life Science Cell Isolation Beads Production, Revenue, Price and Gross Margin (2015 and 2016)
7.7.4 Main Business/Business Overview
7.8 Stemcell Technologies Inc.
7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
7.8.2 Cell Isolation Beads Product Type, Application and Specification
7.8.2.1 Type I
7.8.2.2 Type II
7.8.3 Stemcell Technologies Inc. Cell Isolation Beads Production, Revenue, Price and Gross Margin (2015 and 2016)
7.8.4 Main Business/Business Overview
7.9 Terumo Bct (A Subsidiary of Terumo Corporation)
7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
7.9.2 Cell Isolation Beads Product Type, Application and Specification
7.9.2.1 Type I
7.9.2.2 Type II
7.9.3 Terumo Bct (A Subsidiary of Terumo Corporation) Cell Isolation Beads Production, Revenue, Price and Gross Margin (2015 and 2016)
7.9.4 Main Business/Business Overview
7.10 Bio-Rad Laboratories, Inc.
7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
7.10.2 Cell Isolation Beads Product Type, Application and Specification
7.10.2.1 Type I
7.10.2.2 Type II
7.10.3 Bio-Rad Laboratories, Inc. Cell Isolation Beads Production, Revenue, Price and Gross Margin (2015 and 2016)
7.10.4 Main Business/Business Overview

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=739420

…..Continued

NORAH TRENT
Wise Guy Reports
+91 841 198 5042
email us here

Source: PR